Leerink Partnrs Comments on Henry Schein FY2024 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $4.81 for the year, up from their prior estimate of $4.76. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.26 EPS, Q1 2025 earnings at $1.18 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.30 EPS and Q4 2025 earnings at $1.45 EPS.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period last year, the business earned $1.32 earnings per share. The business’s revenue for the quarter was up .4% on a year-over-year basis.

A number of other brokerages have also recently weighed in on HSIC. JPMorgan Chase & Co. dropped their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. UBS Group dropped their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday. Finally, Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Stock Down 2.1 %

Henry Schein stock opened at $68.00 on Thursday. The company has a market capitalization of $8.62 billion, a PE ratio of 25.19, a price-to-earnings-growth ratio of 2.08 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. Henry Schein has a fifty-two week low of $62.12 and a fifty-two week high of $82.63. The firm has a 50 day moving average price of $70.51 and a 200 day moving average price of $69.75.

Institutional Trading of Henry Schein

Several institutional investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. raised its stake in Henry Schein by 11.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company’s stock worth $2,186,000 after acquiring an additional 2,954 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Henry Schein by 8.9% during the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after purchasing an additional 798 shares in the last quarter. Daiwa Securities Group Inc. lifted its holdings in shares of Henry Schein by 11.0% in the 1st quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company’s stock valued at $972,000 after purchasing an additional 1,279 shares during the last quarter. Empirical Finance LLC boosted its position in shares of Henry Schein by 3.5% in the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after purchasing an additional 160 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its stake in Henry Schein by 64.2% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after buying an additional 16,241 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.